Efficacy of an electronic intervention for adolescent suicide attempters
A Multi-centric Trial to Evaluate the Efficacy of Electronic-Based Psychosocial Interventions on Future Suicide Risk Among Adolescent Suicide Attempters
This study tests a new online program to help teenagers who have recently tried to harm themselves improve their coping skills and reduce the chances of future suicide attempts.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 168 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 2 sites (Bengaluru, Karnataka and 1 other locations) |
| Trial ID | NCT06474221 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an Electronic Based Psychosocial Intervention (EBPSI) aimed at improving coping and problem-solving skills among adolescents who have recently attempted suicide. The research involves screening participants for eligibility, obtaining consent, conducting baseline assessments, randomizing participants, implementing the intervention, and performing follow-up assessments. The goal is to enhance accessibility to care and reduce future suicidal behavior in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 12-18 who have attempted suicide within the last thirty days and are medically stable.
Not a fit: Patients with current or lifetime diagnoses of psychosis, serious medical illnesses, or substance dependence may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce future suicide risk among adolescents who have attempted suicide.
How similar studies have performed: Other studies have shown promise in using electronic interventions for mental health, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All adolescents who have attempted suicide within the last thirty days and presented to the study site * Between ages of 12-18 years * Participants of all gender will be included * Medically stable patients who have stable blood pressure, breathing rates without fever, and intact orientation to time, place, and person Exclusion Criteria: * A current or a lifetime diagnosis of psychosis. We will confirm the same using a detailed clinical interview according to ICD-10 diagnostic guidelines. * A history of mental retardation and any neurological condition causing cognitive impairment. * A diagnosis of substance dependence as confirmed by M.I.N.I. KID 6.0 over the last six months. We will include those with tobacco dependence. * A diagnosis of serious medical illness like end-stage cancer, AIDS, less than a month following acute cardiovascular and cerebrovascular events.
Where this trial is running
Bengaluru, Karnataka and 1 other locations
- St John's Medical College and Hospital — Bengaluru, Karnataka, India (Recruiting)
- Kalinga Institute of Medical Sciences (KIMS), — Bhubaneswar, Odisha, India (Recruiting)
Study contacts
- Principal investigator: Vishwajit L Nimgaonkar, MD, PhD — University of Pittsburgh
- Study coordinator: Vishwajit L Nimgaonkar, MD, PhD
- Email: vishwajitnl@upmc.edu
- Phone: 4127265164
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.